Medimetriks reports Phase II data for MM36 in atopic dermatitis

In September, Medimetriks Pharmaceuticals Inc. (Fairfield, N.J.) reported data from the Phase II MUSE trial in 32 patients with atopic dermatitis showing that twice-daily topical

Read the full 255 word article

User Sign In